Published in Pediatr Infect Dis J on September 01, 1999
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev (2003) 2.90
Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis (2009) 1.22
Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer (2010) 1.18
Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. J Infect Dis (2007) 1.16
Human herpesvirus 8--a novel human pathogen. Virol J (2005) 1.00
Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci U S A (2000) 0.94
The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res (2013) 0.90
The Zambia Children's KS-HHV8 Study: rationale, study design, and study methods. Am J Epidemiol (2011) 0.82
Kaposi`s sarcoma associated herpesvirus infection among female sex workers and general population women in Shanghai, China: a cross-sectional study. BMC Infect Dis (2014) 0.79
High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population. Med Microbiol Immunol (2016) 0.77
Risk of occupational human herpesvirus 8 infection for health care workers. J Clin Microbiol (2003) 0.75
Construct design for efficient, effective and high-throughput gene silencing in plants. Plant J (2001) 7.73
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med (1995) 6.71
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res Hum Retroviruses (1991) 3.78
Nuclear gene silencing directs reception of long-distance mRNA silencing in Arabidopsis. Proc Natl Acad Sci U S A (2007) 2.64
Prospective validation of a decision rule for the use of radiography in acute knee injuries. JAMA (1996) 2.53
Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol (1997) 2.42
Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol (1999) 2.36
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet (1998) 2.32
Lumbar spinal stenosis and nerve root entrapment syndromes. Definition and classification. Clin Orthop Relat Res (1976) 2.25
Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol (2000) 2.05
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology (2009) 2.00
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99
Patient-delivered partner medication in the UK: an unlawful but popular choice. Int J STD AIDS (2007) 1.91
Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol (1999) 1.90
Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol (1989) 1.87
Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis (1998) 1.79
C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3. Infect Immun (1989) 1.76
Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle. Virology (1993) 1.74
A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients. Q J Med (1971) 1.72
C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care (1991) 1.67
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J Virol (1999) 1.66
Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med (2000) 1.64
Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer (1998) 1.61
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
An evaluation of a thicker versus a standard condom with gay men. AIDS (2001) 1.55
Development and degeneration of retina in rds mutant mice: light microscopy. J Comp Neurol (1980) 1.53
Hematologic findings in certain small cetaceans. J Am Vet Med Assoc (1970) 1.52
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
The ilvB locus of Escherichia coli K-12 is an operon encoding both subunits of acetohydroxyacid synthase I. Nucleic Acids Res (1985) 1.49
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol (1997) 1.47
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet (1990) 1.47
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
Derivation of a decision rule for the use of radiography in acute knee injuries. Ann Emerg Med (1995) 1.46
Cell cycle dependence of foamy retrovirus infection. J Virol (1995) 1.45
Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients. AIDS (2001) 1.44
Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H. Biochem J (1984) 1.44
Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates? J Virol (2000) 1.44
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes. Metabolism (1966) 1.41
bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40
Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol (1994) 1.40
Replicating satellite RNA induces sequence-specific DNA methylation and truncated transcripts in plants. RNA (2001) 1.39
Changes in brain maturation detected by magnetic resonance imaging in congenital hypothyroidism. J Pediatr (1989) 1.38
"Does ligase chain reaction assay of urine in the diagnosis of Chlamydia trachomatis offer significant improvement over existing diagnostic tests?"--a critical appraisal of the evidence. Genitourin Med (1996) 1.38
Veterinary nursing examinations. Vet Rec (1994) 1.38
A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology (1995) 1.37
Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS (1998) 1.34
Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32
Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts. Int J Cancer (1989) 1.31
Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation (2001) 1.31
Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30
Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol (1999) 1.29
HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9. AIDS (1992) 1.29
The human herpesvirus-8 ORF 57 gene and its properties. J Gen Virol (1999) 1.25
Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer (1998) 1.25
Somatostatin. Physiology and clinical applications. Med Clin North Am (1978) 1.24
Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem J (1985) 1.24
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant (2006) 1.19
Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging. J Virol (2000) 1.18
Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18
Why I shall stay in rural practice. Can Fam Physician (1987) 1.17
Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group. AIDS (1999) 1.17
Sequences in pol are required for transfer of human foamy virus-based vectors. J Virol (1998) 1.15
Gastric A-cell function in insulin-deprived depancreatized dogs. Endocrinology (1976) 1.15
HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy. AIDS (1998) 1.13
No evidence of antibody to human foamy virus in widespread human populations. AIDS Res Hum Retroviruses (1996) 1.13
Use of monoclonal antibodies against factor H to investigate the role of a membrane-associated protein antigenically related to H in C3b-receptor function. J Immunol (1984) 1.12
The immunoassay of insulin in human serum treated with sodium ethylene diamine tetra-acetate. J Endocrinol (1965) 1.11
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol (2001) 1.10
Rubella vaccines. Lancet (1979) 1.10
Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol (1999) 1.09
Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Med Vet Entomol (2003) 1.08
Persistence of rubella antibodies after vaccination: detection after experimental challenge. Rev Infect Dis (1985) 1.08
Origin of AIDS. Lancet (1992) 1.07
Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors. AIDS Res Hum Retroviruses (1993) 1.07
Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J Virol (1997) 1.07
C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med (1995) 1.06
Isolation of a new foamy retrovirus from orangutans. J Virol (1994) 1.06
Detection in chimpanzees of a novel flavivirus related to GB virus-C/hepatitis G virus. J Gen Virol (1998) 1.06
Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur J Immunol (1987) 1.06
Envelope gene-derived recombinant peptide in the serodiagnosis of human immunodeficiency virus infection. Lancet (1986) 1.06
Health beliefs, satisfaction and compliance. Patient Educ Couns (1987) 1.06